Elimination of rheumatoid factor interference using anti-FD antibodies

US5804391A · kind A · utility

Assignee

• Boehringer Mannheim GmbH · DE

Inventors

• Volker Klemt · Waldshut-Tiengen, DE
• Dittmar Schlieper · Weilheim, DE
• Urban Schmitt · Oberhausen, DE
• Michael Wiedmann · Penzberg, DE

Key dates

• Filing date: Apr 11, 1997
• Grant date: Sep 8, 1998
• Expiry date: Apr 11, 2017

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S530/866
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention concerns the use of a composition which is composed of several different antibodies or/and antibody fragments which serves as a reagent to eliminate rheumatoid factor interference in an immunochemical method.